androgen independent prostate cancer
Showing 9976 - 10000 of >10,000
Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan
Active, not recruiting
- Childhood Solid Neoplasm
- +4 more
- Irinotecan Hydrochloride
- +4 more
-
Birmingham, Alabama
- +20 more
Feb 1, 2023
Rectal Tumors, Robotic Surgery, Natural Orifice Specimen Extraction Surgery Trial in China (Transanal specimen extraction
Not yet recruiting
- Rectal Neoplasms
- +2 more
- Transanal specimen extraction robotic surgery
- Transabdominal specimen extraction robotic surgery
-
Beijing, China
- +11 more
Jul 20, 2022
Lung Cancer, Gastrointestinal Cancer, Head Neck Cancer Trial (ChatBot)
Not yet recruiting
- Lung Cancer
- +2 more
- ChatBot
- (no location specified)
Feb 2, 2023
Aortic Dissection Trial (AMDS; Artivion, Atlanta, Georgia, US, Conventional hemiarch replacement)
Not yet recruiting
- Aortic Dissection
- AMDS; Artivion, Atlanta, Georgia, US
- Conventional hemiarch replacement
- (no location specified)
Sep 16, 2023
Metastatic Colorectal Cancer, BRAF V600E Mutation Positive Trial in France (Collection of blood samples)
Not yet recruiting
- Metastatic Colorectal Cancer
- BRAF V600E Mutation Positive
- Collection of blood samples
-
Avignon, France
- +26 more
Nov 25, 2022
Anaplastic Large Cell Lymphoma, ALK-Negative, Anaplastic Large Cell Lymphoma, ALK-Positive, Hepatosplenic T-Cell Lymphoma Trial
Completed
- Anaplastic Large Cell Lymphoma, ALK-Negative
- +9 more
- Autologous Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, California
- +7 more
Nov 4, 2022
Cancer Therapy-Related Diarrhea, Chemo-related Diarrhea, Adult Solid Tumor Trial in United States (Crofelemer 125 MG [Mytesi],
Recruiting
- Cancer Therapy-Related Diarrhea
- +5 more
- Crofelemer 125 MG [Mytesi]
- Placebo
-
Corona, California
- +13 more
May 2, 2022
"Don't Eat me" Signal in Hematological Malignancies: CD24 as New
Recruiting
- Mantle-cell Lymphoma
- B Cell Chronic Lymphocytic Leukemia
-
Monza, MB, ItalyAndrea Aroldi
May 24, 2023
Breast Cancer Trial in Zhengzhou (utidelone, Bevacizumab)
Recruiting
- Breast Cancer
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Sep 15, 2022
Treatment Side Effects, Colorectal Cancer Trial (Tumor removal)
Not yet recruiting
- Treatment Side Effects
- Colorectal Cancer
- Tumor removal
- (no location specified)
Sep 21, 2023
Cancer, Coping Skills, Coping Behavior Trial in United States (IN FOCUS, Usual Care)
Active, not recruiting
- Cancer
- +2 more
- IN FOCUS
- Usual Care
-
Boston, Massachusetts
- +4 more
Jul 25, 2022
Anastomotic Complication Trial in Montréal (Inulin, Placebo)
Not yet recruiting
- Anastomotic Complication
- Inulin
- Placebo
-
Montréal, Quebec, CanadaCentre hospitalier de l'Université de Montréal (CHUM)
May 5, 2023
Chronic Atrophic Gastritis Trial in Santa Rosa De Copan, San Juan (Curcumin, Laboratory Biomarker Analysis, Placebo
Active, not recruiting
- Chronic Atrophic Gastritis
- Curcumin
- +3 more
-
Santa Rosa De Copan, Honduras
- +1 more
Dec 17, 2022
Ovarian Tumors, BRCA1 Protein, BRCA2 Protein Trial in Worldwide (KU-0059436 (AZD2281)(PARP inhibitor))
Active, not recruiting
- Ovarian Neoplasms
- +2 more
- KU-0059436 (AZD2281)(PARP inhibitor)
-
Brussels, Belgium
- +4 more
Dec 19, 2022
Cervical Cancer, Head and Neck Squamous Cell Carcinoma, NSCLC Trial in Boston, Saint Louis (ITIL-168)
Withdrawn
- Cervical Cancer
- +2 more
- ITIL-168
- (no location specified)
Dec 16, 2022
Solid Tumor Malignancy, Hematologic Malignancy, Leukemia Trial run by the NCI (mrna 1273 injection)
Recruiting
- Solid Tumor Malignancy
- +4 more
- mRNA-1273
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 14, 2023
Colorectal Cancer, Lynch Syndrome Trial in Kansas City (Omega-3 fatty acid ethyl esters (2 gram))
Active, not recruiting
- Colorectal Cancer
- Lynch Syndrome
- Omega-3 fatty acid ethyl esters (2 gram)
-
Kansas City, KansasThe University of Kansas Cancer Center, Westwood Campus
Nov 7, 2022
Stage 0 Bladder Urothelial Carcinoma, Stage 0is Bladder Urothelial Carcinoma, Stage I Bladder Urothelial Carcinoma Trial in
Active, not recruiting
- Stage 0 Bladder Urothelial Carcinoma
- +2 more
- BCG Solution
- +3 more
-
Mobile, Alabama
- +173 more
Mar 8, 2022
Gastric Cancer, Small-cell Lung Cancer Trial in China, Korea, Republic of, Taiwan (EP0057, Olaparib tablets)
Not yet recruiting
- Gastric Cancer
- Small-cell Lung Cancer
- EP0057
- Olaparib tablets
-
Shanghai, Changning District, 交通大学 邮政编码, China
- +20 more
Nov 1, 2022
Advanced Biliary Tract Cancer Trial in Guangzhou (Envofolimab, Lenvatinib, Gemcitabine)
Recruiting
- Advanced Biliary Tract Cancer
- Envofolimab
- +3 more
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Sun Yat-sen University
Oct 11, 2022
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial
Active, not recruiting
- Fallopian Tube Clear Cell Adenocarcinoma
- +14 more
- Cediranib
- +9 more
-
Birmingham, Alabama
- +399 more
Dec 30, 2022
Pancreatic Cancer, Hepatocellular Cancer, Biliary Tract Cancer Trial in Edmonton (Durvalumab, Gemcitabine, Nab paclitaxel)
Not yet recruiting
- Pancreatic Cancer
- +3 more
- Durvalumab
- +5 more
-
Edmonton, Alberta, CanadaCross Cancer Institute
Feb 1, 2023
Cardiotoxicity, Toxicity Due to Chemo, Breast Cancer Trial in Duarte, Philadelphia, West Chester (Biomarker Guided Intervention)
Recruiting
- Cardiotoxicity
- +5 more
- Biomarker Guided Intervention
-
Duarte, California
- +2 more
Jul 29, 2022
Locally Advanced Cervical Cancer Trial in Chongqing (Candonilimab(AK104), EBRT, BT)
Recruiting
- Locally Advanced Cervical Cancer
- Candonilimab（AK104）
- +2 more
-
Chongqing, CHN, ChinaChongqing university Cancer Hospital
Jan 15, 2023
